ProShare Advisors LLC Has $8.94 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

ProShare Advisors LLC increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 9.5% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 29,767 shares of the company's stock after purchasing an additional 2,583 shares during the quarter. ProShare Advisors LLC's holdings in HCA Healthcare were worth $8,935,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently made changes to their positions in the company. Whipplewood Advisors LLC acquired a new position in HCA Healthcare in the 4th quarter worth approximately $31,000. Tidemark LLC acquired a new stake in HCA Healthcare during the 4th quarter worth approximately $36,000. Activest Wealth Management increased its position in HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company's stock worth $40,000 after buying an additional 125 shares during the period. Legacy Investment Solutions LLC boosted its holdings in HCA Healthcare by 99.0% in the fourth quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock valued at $62,000 after acquiring an additional 95 shares during the last quarter. Finally, Physician Wealth Advisors Inc. purchased a new stake in HCA Healthcare in the 4th quarter valued at about $64,000. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Price Performance

Shares of HCA traded down $3.62 during mid-day trading on Wednesday, hitting $382.43. 1,118,243 shares of the company traded hands, compared to its average volume of 1,433,745. The business has a 50-day moving average of $343.61 and a 200 day moving average of $328.91. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The stock has a market capitalization of $92.00 billion, a price-to-earnings ratio of 17.41, a PEG ratio of 1.10 and a beta of 1.46. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.75 by $0.70. The business had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The firm's revenue was up 5.7% on a year-over-year basis. During the same period last year, the company earned $5.36 EPS. As a group, equities analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.75%. The ex-dividend date is Monday, June 16th. HCA Healthcare's payout ratio is presently 12.81%.

Insider Transactions at HCA Healthcare

In other news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the sale, the chief operating officer now owns 12,646 shares of the company's stock, valued at $4,670,420.72. This represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.30% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on HCA shares. Barclays dropped their target price on shares of HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating for the company in a report on Monday, January 27th. Robert W. Baird reiterated a "neutral" rating and issued a $336.00 target price (down previously from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. StockNews.com raised HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Monday, April 28th. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $405.00 price objective on shares of HCA Healthcare in a report on Monday, January 27th. Finally, Bank of America dropped their price objective on shares of HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, six have issued a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, HCA Healthcare presently has an average rating of "Moderate Buy" and an average target price of $381.13.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.